Prot # ONC-2010-31: A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/129/30/17

Funding

  • University of California, Los Angeles (Prot # ONC-2010-31 // Prot # ONC-2010-31)
  • Bayer HealthCare Pharmaceuticals, Inc. (Prot # ONC-2010-31 // Prot # ONC-2010-31)